The activity of siRNA in mammalian cells is related to structural target accessibility: A comparison with antisense oligonucleotides

Nucleic Acids Research

Volumn 31, Issue 15, 2003, Pages 4417-4424

  Kretschmer Kazemi Far, Rosel ^a   Sczakiel, Georg ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; RNA; SMALL INTERFERING RNA;

ARTICLE; AUTOMATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; GENE INTERACTION; GENE TARGETING; MAMMAL CELL; PREDICTION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN MOTIF; QUANTITATIVE ANALYSIS; STRUCTURE ACTIVITY RELATION; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CHEMISTRY; CONFORMATION; GENETIC TRANSFECTION; GENETICS; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE;

MAMMALIA;

BASE SEQUENCE; CELL LINE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES, ANTISENSE; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0042161890     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg649     Document Type: Article

References (31)

1. Holen,T., Amarzguioui,M., Wiiger,M.T., Babaie,E. and Prydz,H. (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger. Tissue factor. Nucleic Acids Res., 30, 1757-1766.
2. Bohula,E.A., Salisbury,A.J., Sohail,M., Playford,M.P., Riedemann,J., Southern,E.M. and Macaulay,V.M. (2003) The efficacy of small interfering RNAs targeted to the type 1 IGF receptor is influenced by secondary structure in the IGF1R transcript. J. Biol. Chem., 278, 15991-15997.
3. Vickers,T.A., Koo,S., Bennett,C.T., Crooke,S.T., Dean,N.M. and Baker,B.F. (2003) Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J. Biol. Chem., 278, 7108-7118.
4. Elbashir,S.M., Harborth,J., Lendeckel,W., Yalcin,A., Weber,K. and Tuschl,T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494-498.
5. Chiang,M.Y., Zounes,M.A., Lima,W.F. and Bennett,C.F. (1991) Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem., 266, 18162-18171.
6. Patzel,V., Steidl,U., Kronenwett,R., Haas,R. and Sczakiel,G. (1999) A theoretical approach to select effective antisense oligonucleotides at high statistical probability. Nucleic Acids Res., 27, 4328-4334.
7. Scherr,M., Rossi,J.J., Sczakiel,G. and Patzel,V. (2000) RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts. Nucleic Acids Res., 28, 2455-2461.
8. Zuker,M. (1989) On finding all suboptimal foldings of an RNA molecule. Science, 244, 48-52.
9. Mathews,D.H., Sabina,J., Zuker,M. and Turner,D.H. (1999) Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol., 288, 911-940.
10. Rychlik,W. and Rhoads,R.E (1989) A computer program for choosing optimal oligonucleotides for filter hybridization, sequencing and in vitro amplification of DNA. Nucleic Acids Res., 21, 8543-8551.
11. Takahashi,K., Sawasaki,Y., Hata,J., Mukai,K. and Goto,T. (1990) Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev. Biol. Anim., 26, 265-274.
12. Dirks,W.G., MacLeod,R.A. and Drexler,H.G. (1999) ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross-contamination at source. In Vitro Cell Dev. Biol., 35, 558-559.
13. Sczakiel,G. (2000) Theoretical and experimental approaches to design effective antisense oligonucleotides. Frontiers Biosci., 5, 194-201.
14. Lima,W.F., Brown-Driver,V., Fox,M., Hanecak,R. and Bruice,T.W. (1997) Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity. J. Biol. Chem., 272, 626-638.
15. Milner,N., Mir,K.U. and Southern,E.M. (1997) Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nat. Biotechnol., 15, 537-541.
16. Ho,S.P., Bao,Y., Lesher,T., Malhotra,R., Ma,L.Y., Fluharty,S.J. and Sakai,R.R. (1998) Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries. Nat. Biotechnol., 16, 59-63.
17. Bramlage,B., Luzi,E. and Eckstein,F. (2000) HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture. Nucleic Acids Res., 28, 4059-4067.
18. Scherr,M., LeBon,J., Castanotto,D., Cunliffe,H.E., Meltzer,P.S., Ganser,A., Riggs,A.D. and Rossi,J.J. (2001) Detection of antisene and ribozyme accessible sites on native mRNAs. Application to NCOA3 mRNA. Mol. Ther., 4, 454-460.
19. Sczakiel,G. and Kretschmer-Kazemi Far,R. (2002) The role of target accessibility for antisense inhibition. Curr. Opin. Mol. Ther., 4, 149-153.
20. Kretschmer-Kazemi Far,R., Nedbal,W. and Sczakiel,G. (2001) Concepts to automate the theoretical design of effective antisense oligonucleotides. Bioinformatics, 17, 1058-1061.
21. Walters,D.K. and Jelinek,D.F. (2002) The effectiveness of double-stranded short inhibitory RNAs (siRNAs) may depend on the method of transfection. Antisense Nucleic Acid Drug Dev., 12, 411-418.
22. 3 receptor. Nucleic Acids Res., 31, 2117-2126.
23. Miyagishi,M., Hayashi,M. and Taira,K. (2003) Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells. Antisense Nucleic Acid Drug Dev., 13, 1-7.
24. Elbashir,S.M., Martinez,A.P., Lendeckel,W. and Tuschl,T. (2001) Functional anatomy of siRNA for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J., 20, 6877-6888.
25. Hamada,M., Ohtsuka,T., Kawaida,R., Koizumi,M., Morita,K., Furukawa,H., Imanishi,T., Miyagishi,M. and Taira,K. (2002) Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3′-ends of siRNAs. Antisense Nucleic Acid Drug Dev., 12, 301-309.
26. Amarzguioui,M., Brede,G., Babaie,E., Grotli,M., Sproar,B. and Prydz,H. (2000) Secondary structure prediction and in vitro accessibility of mRNA as tools in selection of target sites for ribozymes. Nucleic Acids Res., 28, 4113-4124.
27. Jayaraman,A., Walton,S.P., Yarmush,M.L. and Roth,C.M. (2001) Rational selection and quantitative evaluation of antisense oligonucleotides. Biochim. Biophys. Acta, 1520, 105-114.
28. Southern,E.M., Case-Green,S.C., Elder,J.K., Johnson,M., Mir,K.U., Wang,L. and Williams,J.C. (1994) Arrays of complementary oligonucleotides for analyzing the hybridization behavior of nucleic acids. Nucleic Acids Res., 22, 1368-1373.
29. Rittner,K., Burmester,C. and Sczakiel,G. (1993) In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1. Nucleic Acids Res., 21, 1381-1387.
30. Kawasaki,H., Suyama,E., Iyo,M. and Taira,K. (2003) siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells. Nucleic Acids Res., 31, 981-987.
31. Nedbal,W., Homann,M. and Sczakiel,G. (1997) The association of complementary ribonucleic acids can be greatly increased without lowering the Arrhenius activation energy or significantly altering RNA structure. Biochemistry, 36, 13552-13557.